Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 99.30%
August 31, 2026 99.30%
July 31, 2026 99.30%
June 30, 2026 99.30%
May 31, 2026 99.30%
April 30, 2026 99.30%
March 31, 2026 99.30%
February 28, 2026 99.30%
January 31, 2026 99.30%
December 31, 2025 99.30%
November 30, 2025 99.30%
October 31, 2025 99.30%
September 30, 2025 99.30%
August 31, 2025 99.30%
July 31, 2025 99.30%
June 30, 2025 99.30%
May 31, 2025 99.30%
April 30, 2025 98.43%
March 31, 2025 98.00%
February 28, 2025 97.46%
January 31, 2025 97.11%
December 31, 2024 96.88%
November 30, 2024 96.88%
October 31, 2024 96.88%
September 30, 2024 96.88%
Date Value
August 31, 2024 96.88%
July 31, 2024 96.88%
June 30, 2024 96.88%
May 31, 2024 96.88%
April 30, 2024 96.88%
March 31, 2024 96.88%
February 29, 2024 96.88%
January 31, 2024 96.88%
December 31, 2023 96.88%
November 30, 2023 96.88%
October 31, 2023 96.88%
September 30, 2023 96.88%
August 31, 2023 96.88%
July 31, 2023 96.88%
June 30, 2023 96.88%
May 31, 2023 96.88%
April 30, 2023 96.88%
March 31, 2023 96.88%
February 28, 2023 96.88%
January 31, 2023 96.88%
December 31, 2022 96.88%
November 30, 2022 96.88%
October 31, 2022 96.88%
September 30, 2022 96.03%
August 31, 2022 95.77%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Quest Diagnostics, Inc. 28.60%
Labcorp Holdings, Inc. 34.60%
OPKO Health, Inc. 85.55%
Psychemedics Corp. 87.72%
NeoGenomics, Inc. 91.92%